Atlas Trials

A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin

Clinical trial NCT00870194 · COMPLETED

Trial details

NCT number
NCT00870194
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2009-03-01
Primary completion
2010-04-01
Enrollment
255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.